Desenlace funcional y hemoglobina en pacientes neurocríticos con hemorragia subaracnoidea a 2600 msnm

dc.contributorCarrizosa Gonzalez, Jorge Armando
dc.contributorCarreño Rodríguez, José Nel
dc.creatorPalomino Mantilla, Carlos Mario
dc.date.accessioned2020-02-14T20:31:20Z
dc.date.accessioned2022-09-22T14:05:24Z
dc.date.available2020-02-14T20:31:20Z
dc.date.available2022-09-22T14:05:24Z
dc.date.created2020-02-14T20:31:20Z
dc.identifierhttps://repository.urosario.edu.co/handle/10336/20883
dc.identifierhttps://doi.org/10.48713/10336_20883
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3435721
dc.description.abstractIntroduction: subarachnoid hemorrhage (SAH) is a devastating pathology of the central nervous system, with high morbidity and mortality. Clinical trials of pharmacological therapies may not be affected by the patient's geographic location, particularly by height as therapy with blood products whose relationship with atmospheric pressure and oxygen transport generates areas of uncertainty in cities of higher altitude. Objective: To evaluate the relationship of favorable neurological functional outcome (modified Rankin <3) vs. unfavorable (modified Rankin  4) with a cut-off point of 10 gr / dl hemoglobin prior to transfusion in patients diagnosed with subarachnoid hemorrhage, hospitalized in the neurocritical care unit of the Santa Fe de Bogotá Foundation at 2600 ms. n. m. Methodology: Retrospective observational study of cases and controls based on a historical cohort of patients with SAH, from January 2010 to December 2018 in the Neurological Intensive Care Unit. Results: No relationship was found between favorable functional outcome and transfusion with hemoglobin level with cut-off point of 10 gr / dL OR 1,111 (p = 0.865 95% CI 0.328 - 3.755) Conclusion: A favorable or unfavorable association between the hemoglobin cut-off point and the functional neurological outcome was not demonstrated, it is not possible to make a recommendation against the transfusion threshold. No deleterious effect of blood transfusion was evident, no increase in episodes of spasm vessel or late cerebral ischemia.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherEspecialización en Medicina Crítica y Cuidado Intensivo
dc.publisherFacultad de Medicina
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.rightsFundacion Santa Fe De Bogota
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.sourceM. V, M. A. Subarachnoid hemorrhage: A neurological emergency. Open Crit Care Med J [Internet]. 2011;4:56–60. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed10&NEWS=N&AN=2011427138
dc.sourceRosenberg NF, Koht A, Naidech AM. Anemia and transfusion after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesth [Internet]. 2013;25(1):66–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23047622
dc.sourceAbulhasan YB, Alabdulraheem N, Simoneau G, Angle MR, Teitelbaum J. Mortality after Spontaneous Subarachnoid Hemorrhage: Causality and Validation of a Prediction Model. World Neurosurg [Internet]. 2018;112:e799–811. Available from: https://doi.org/10.1016/j.wneu.2018.01.160
dc.sourceNassar HGE, Ghali AA, Bahnasy WS, Elawady MM. Vasospasm following aneurysmal subarachnoid hemorrhage: prediction, detection, and intervention. Egypt J Neurol Psychiatry Neurosurg. 2019;55(1)
dc.sourceZacharia BE, Hickman ZL, Grobelny BT, DeRosa P, Kotchetkov I, Ducruet AF, et al. Epidemiology of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am. 2010/04/13. 2010;21(2):221–33.
dc.sourceLelubre C, Bouzat P, Crippa IA, Taccone FS. Anemia management after acute brain injury. Crit Care [Internet]. 2016;20(1):1–11. Available from: http://dx.doi.org/10.1186/s13054-016-1321-6
dc.sourceMejía C JA, Niño de Mejía MC, Ferrer Z LE, Cohen M D. Vasoespasmo cerebral secundario a hemorragia subaracnoidea por ruptura de aneurisma intracerebral. Rev Colomb Anestesiol [Internet]. 2007;35:143–62. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-33472007000200006&nrm=iso
dc.sourceLee Y, Zuckerman SL, Mocco J. Current Controversies in the Prediction, Diagnosis, and Management of Cerebral Vasospasm: Where Do We Stand? Neurol Res Int [Internet]. 2013;2013:373458. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817677/
dc.sourceDiringer MN, Zazulia AR. Aneurysmal Subarachnoid Hemorrhage: Strategies for Preventing Vasospasm in the Intensive Care Unit. Semin Respir Crit Care Med. 2017;38(6):760–7.
dc.sourcede Oliveira Manoel AL, Goffi A, Marotta TR, Schweizer TA, Abrahamson S, Macdonald RL. The critical care management of poor-grade subarachnoid haemorrhage. Crit Care [Internet]. 2016;20(1):1–19. Available from: http://dx.doi.org/10.1186/s13054-016-1193-9
dc.sourceNaidech AM, Shaibani A, Garg RK, Duran IM, Liebling SM, Bassin SL, et al. Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care. 2010/08/19. 2010;13(3):313–20.
dc.sourceElterman J, Brasel K, Brown S, Bulger E, Christenson J, Kerby JD, et al. Transfusion of red blood cells in patients with a prehospital Glasgow Coma Scale score of 8 or less and no evidence of shock is associated with worse outcomes. J Trauma Acute Care Surg. 2013;75(1):8–14.
dc.sourceKramer AH, Zygun DA, Bleck TP, Dumont AS, Kassell NF, Nathan B. Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care [Internet]. 2009;10. Available from: http://dx.doi.org/10.1007/s12028-008-9137-0
dc.sourceKramer AH, Diringer MN, Suarez JI, Naidech AM, Macdonald LR, Le Roux PD. Red blood cell transfusion in patients with subarachnoid hemorrhage: a multidisciplinary North American survey. Crit Care [Internet]. 2011;15(1):1–11. Available from: http://dx.doi.org/10.1186/cc9977
dc.sourceDhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke [Internet]. 2009/07/25. 2009;40(9):3039–44. Available from: http://dx.doi.org/10.1161/STROKEAHA.109.556159
dc.sourceFestic E, Rabinstein AA, Freeman WD, Mauricio EA, Robinson MT, Mandrekar J, et al. Blood Transfusion is an Important Predictor of Hospital Mortality Among Patients with Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care [Internet]. 2013;18(2):209–15. Available from: http://dx.doi.org/10.1007/s12028-012-9777-y
dc.sourceKiser T. Cerebral Vasospasm in Critically Ill Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions? Hosp Pharm [Internet]. 2014;49(10):923–41. Available from: http://archive.hospital-pharmacy.com/doi/abs/10.1310/hpj4910-923
dc.sourceYokose N, Sakatani K, Murata Y, Awano T, Igarashi T, Nakamura S, et al. Bedside monitoring of cerebral blood oxygenation and hemodynamics after aneurysmal subarachnoid hemorrhage by quantitative time-resolved near-infrared spectroscopy. World Neurosurg [Internet]. 2010;73(5):508–13. Available from: http://dx.doi.org/10.1016/j.wneu.2010.02.061
dc.sourceChang TR, Naval NS, Carhuapoma JR. Controversies in Neurosciences Critical Care. Anesthesiol Clin [Internet]. 2012;30(2):369–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22901615
dc.sourceBroessner G, Lackner P, Hoefer C, Beer R, Helbok R, Grabmer C, et al. Influence of red blood cell transfusion on mortality and long-term functional outcome in 292 patients with spontaneous subarachnoid hemorrhage. Crit Care Med. 2009;37(6):1886–92.
dc.sourceKramer AH, Zygun DA. Anemia and red blood cell transfusion in neurocritical care. Crit Care [Internet]. 2009;13(3):R89. Available from: http://dx.doi.org/10.1186/cc7916
dc.sourceMcLellan SA, Walsh TS. Oxygen delivery and haemoglobin. Contin Educ Anaesthesia, Crit Care Pain. 2004;4(4):123–6.
dc.sourceOMS | Las 10 causas principales de defunción en el mundo. WHO [Internet]. 2014; Available from: http://www.who.int/mediacentre/factsheets/fs310/es/
dc.sourceLantigua H, Ortega-Gutierrez S, Schmidt JM, Lee K, Badjatia N, Agarwal S, et al. Subarachnoid hemorrhage: who dies, and why? Crit Care [Internet]. 2015;19(1):309. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556224/
dc.sourceTurner CL, Budohoski K, Smith C, Hutchinson PJ, Kirkpatrick PJ. Elevated baseline C-reactive protein as a predictor of outcome after aneurysmal subarachnoid hemorrhage: Data from the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) trial. Neurosurgery. 2015;77(5):786–92.
dc.sourceD’Souza S, D’Souza S. Aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol [Internet]. 2015;27(3):222–40. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463029/
dc.sourceWalsh TS, Lee RJ, Maciver CR, Garrioch M, Mackirdy F, Binning AR, et al. Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med. 2005/12/06. 2006;32(1):100–9.
dc.sourceHebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med [Internet]. 1999;340. Available from: http://dx.doi.org/10.1056/NEJM199902113400601
dc.sourceHebert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med. 1997/05/01. 1997;155(5):1618–23.
dc.sourcePrakash D. Anemia in the ICU: anemia of chronic disease versus anemia of acute illness. Crit Care Clin. 2012/06/21. 2012;28(3):333–43, v.
dc.sourceHolst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. Bmj. 2015/03/26. 2015;350:h1354.
dc.sourceLelubre C, Vincent JL, Taccone FS. Red blood cell transfusion strategies in critically ill patients: lessons from recent randomized clinical studies. Minerva Anestesiol. 2016/01/13. 2016;
dc.sourceHolst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med [Internet]. 2014/10/02. 2014;371(15):1381–91. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1406617
dc.sourceLeRoux P. Haemoglobin management in acute brain injury. Curr Opin Crit Care [Internet]. 2013;19(2). Available from: http://journals.lww.com/co-criticalcare/Fulltext/2013/04000/Haemoglobin_management_in_acute_brain_injury.4.aspx
dc.sourceEnglish SW, Chasse M, Turgeon AF, Tinmouth A, Boutin A, Pagliarello G, et al. Red blood cell transfusion and mortality effect in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis protocol. Syst Rev [Internet]. 2015;4:41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25927348
dc.sourceBell DL, Kimberly WT, Yoo AJ, Leslie-Mazwi TM, Rabinov JD, Bell JE, et al. Low neurologic intensive care unit hemoglobin as a predictor for intra-arterial vasospasm therapy and poor discharge modified Rankin Scale in aneurysmal subarachnoid haemorrhage-induced cerebral vasospasm. J Neurointerv Surg [Internet]. 2015;7(6):438–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24814068
dc.sourceKurtz P, Schmidt JM, Claassen J, Carrera E, Fernandez L, Helbok R, et al. Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage. Neurocrit Care [Internet]. 2010;13(1):10–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20383611
dc.sourceOddo M, Milby A, Chen I, Frangos S, MacMurtrie E, Maloney-Wilensky E, et al. Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke [Internet]. 2009 Apr [cited 2016 Oct 1];40(4):1275–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19265059
dc.sourceTaccone FS, Citerio G, Le Roux P, Menon DK, Vespa P, Bader MK, et al. Advanced Monitoring of Systemic Hemodynamics in Critically Ill Patients with Acute Brain Injury. Neurocrit Care [Internet]. 2014/09/12. 2014;21(S2):38–63. Available from: http://link.springer.com/10.1007/s12028-014-0033-5
dc.sourceLe Roux PD. Anemia and transfusion after subarachnoid hemorrhage. Neurocrit Care [Internet]. 2011;15(2):342–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21769459
dc.sourceHao Z, Wu B, Wang D, Lin S, Tao W, Liu M. A cohort study of patients with anemia on admission and fatality after acute ischemic stroke. J Clin Neurosci [Internet]. 2013;20(1):37–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23117142
dc.sourceSampson TR, Dhar R, Diringer MN. Factors associated with the development of anemia after subarachnoid hemorrhage. Neurocrit Care [Internet]. 2009/09/25. 2010;12(1):4–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19777386
dc.sourceFergusson D, Montroy K, Pagliarello G, Griesdale D, Chassé M, Garland A, et al. Anemia prevalence and incidence and red blood cell transfusion practices in aneurysmal subarachnoid hemorrhage: Results of a multicenter cohort study. Crit Care. 2018;22(1):1–9.
dc.sourceNaidech AM, Jovanovic B, Wartenberg KE, Parra A, Ostapkovich N, Connolly ES, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med [Internet]. 2007;35(10):2383–9. Available from: http://dx.doi.org/10.1097/01.CCM.0000284516.17580.2C
dc.sourceOrganization WH. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitam Miner Nutr Inf Syst. 2011;WHO/NMH/NH(World Health Organization):6.
dc.sourceMarik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature. Crit Care Med. 2008/08/06. 2008;36(9):2667–74.
dc.sourceKshettry VR, Rosenbaum BP, Seicean A, Kelly ML, Schiltz NK, Weil RJ. Incidence and risk factors associated with in-hospital venous thromboembolism after aneurysmal subarachnoid hemorrhage. J Clin Neurosci [Internet]. 2014;21(2):282–6. Available from: http://dx.doi.org/10.1016/j.jocn.2013.07.003
dc.sourceEtminan N. Aneurysmal subarachnoid hemorrhage--status quo and perspective. Transl Stroke Res. 2015/04/11. 2015;6(3):167–70.
dc.sourceAyling OGS, Ibrahim GM, Alotaibi NM, Gooderham PA, Macdonald RL. Anemia After Aneurysmal Subarachnoid Hemorrhage Is Associated With Poor Outcome and Death. Stroke. 2018;49(8):1859–65.
dc.sourcede Rooij NK, Rinkel GJE, Dankbaar JW, Frijns CJM. Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Systematic Review of Clinical, Laboratory, and Radiological Predictors. Stroke [Internet]. 2012;43–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23250997
dc.sourceInagawa T. Risk Factors for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage: A Review of the Literature. World Neurosurg [Internet]. 2016;85:56–76. Available from: http://dx.doi.org/10.1016/j.wneu.2015.08.052
dc.sourceDasenbrock HH, Rudy RF, Lai PMR, Smith TR, Frerichs KU, Gormley WB, et al. Cigarette smoking and outcomes after aneurysmal subarachnoid hemorrhage: A nationwide analysis. J Neurosurg. 2018;129(2):446–57.
dc.sourceKumar G, Shahripour RB, Harrigan MR. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2015;124(May):1257–64.
dc.sourceWartenberg KE, Schmidt JMM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, et al. Impact of medical complications on outcome after subarachnoid hemorrhage*. Crit Care Med [Internet]. 2006;34(3). Available from: http://dx.doi.org/10.1097/00003246-200612002-00426
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectHemoglobina
dc.subjectAltitud
dc.subjectHemorragia Subaracnoidea
dc.subjectTransfusión
dc.subjectFuncionalidad
dc.titleDesenlace funcional y hemoglobina en pacientes neurocríticos con hemorragia subaracnoidea a 2600 msnm
dc.typemasterThesis


Este ítem pertenece a la siguiente institución